英文原著
1. Hashimoto K, et al. Blood data trends of children in Fukushima after the Great East Japan Earthquake. Pediatr Int in press pubmed
2. Honda K, et al. Relationship between evacuation after the Great East Japan Earthquake and new-onset hyperuricemia: A 7-year prospective longitudinal study of the Fukushima Health Management Survey. PLoS ONE in press pubmed
2. Honda K, et al. Relationship between evacuation after the Great East Japan Earthquake and new-onset hyperuricemia: A 7-year prospective longitudinal study of the Fukushima Health Management Survey. PLoS ONE in press pubmed
3. Hosoya M, et al. Influence of post-disaster evacuation on childhood obesity and liver dysfunction. Pediatr Int in press pubmed
4. Kimura H, et al. Impact of red blood cell distribution width-albumin ratio on prognosis of patients with CKD. Sci Rep in press
5. Kudo A , Machii N, Ono T, Saito H, Oshiro Y, Takahashi T, Oshiro K, Taneda Y, Higa M, Nakachi K, Yagi S, Masuzaki H, Sata M, Shimabukuro M. Effect of dapagliflozin on 24-h glycaemic variables in Japanese patients with type 2 diabetes mellitus receiving basal insulin supported oral therapy (DBOT): a multicentre, randomised, open-label, parallel-group study. BMJ Open Diabetes Res Care in press pubmed
6. Sato S, et al. Validation and modification of the AFHCHDC7 risk score for predicting the long-term cardiovascular disease risk after the Great East Japan Earthquake: The Fukushima Health Management Survey. Int J Disaster Risk Reduc pubmed
7. Shiroma K, Tanabe H, Takiguchi Y, Yamaguchi M, Sato M, Saito H, Tanaka K, Masuzaki H, Kazama JJ, Shimabukuro M. A nutritional assessment tool, GNRI, predicts sarcopenia and its components in type 2 diabetes mellitus: A Japanese cross-sectional study. Front Nutr 2023;10:1087471. pubmed
8. Takahashi A et al. Impact of lifestyle and psychosocial factors on the incidence of hepatobiliary enzyme abnormalities after the Great East Japan Earthquake: Seven-year follow-up of the Fukushima Health Management Survey. Disaster Med Public Health Prep in press pubmed
9. Tanaka A, Okada Y, Torimoto K et al. Effect of ipragliflozin on endothelial dysfunction in patients with type 2 diabetes and chronic kidney disease: a randomized clinical trial (PROCEED). Diabetes Metab in press pubmed
10. Tanaka A, et al. Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: A multicenter, prospective, exploratory study (DIANA). Eur J Med Res in press pubmed
11. Tanaka A, et al. Rationale and design of an investigator-initiated, multicenter, prospective, placebo- controlled, double-blind, randomized trial to evaluate the effects of finerenone on vascular stiffness and cardiorenal biomarkers in type 2 diabetes and chronic kidney disease (FIVE-STAR). Cardiovasc Diabetol in press pubmed
12. Pham PT, et al. Innate immune system regulated by STING, a cytosolic DNA sensor, regulates endothelial function. JAHA in press pubmed
13. Yamaguchi S, et al. Sex differences in the association between epicardial adipose tissue volume and left atrial volume index. BMC Cardiovasc Dis in press pubmed
9. Tanaka A, Okada Y, Torimoto K et al. Effect of ipragliflozin on endothelial dysfunction in patients with type 2 diabetes and chronic kidney disease: a randomized clinical trial (PROCEED). Diabetes Metab in press pubmed
10. Tanaka A, et al. Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: A multicenter, prospective, exploratory study (DIANA). Eur J Med Res in press pubmed
11. Tanaka A, et al. Rationale and design of an investigator-initiated, multicenter, prospective, placebo- controlled, double-blind, randomized trial to evaluate the effects of finerenone on vascular stiffness and cardiorenal biomarkers in type 2 diabetes and chronic kidney disease (FIVE-STAR). Cardiovasc Diabetol in press pubmed
12. Pham PT, et al. Innate immune system regulated by STING, a cytosolic DNA sensor, regulates endothelial function. JAHA in press pubmed
13. Yamaguchi S, et al. Sex differences in the association between epicardial adipose tissue volume and left atrial volume index. BMC Cardiovasc Dis in press pubmed
14. Zheng MH, et al. Metabolic dysfunction-associated fatty liver disease increases risk of chronic kidney disease: a systematic review and meta-analysis. eGastroenterology in press pubmed
英文総説
1. Sakuma M. et al. Possible biomarkers to detect vascular failure: What is known? What should be elucidated? Vasc Fail in press Pubmed
2. Shimabukuro M. L-arginine, nitric oxide, and endothelial dysfunction underlying atherosclerotic cardiovascular disease (ASCVD). J Atheroscler Thromb in press Pubmed
3. Shimabukuro M. Nonsteroidal mineralocorticoid receptor antagonists and protection against cardiovascular disease in patients with diabetes mellitus. J Atheroscler Thromb in press Pubmed
4. Shimabukuro M. MAFLD and ASCVD: plasma heparin cofactor II activity as an anti-liver fibrosis biomarker. J Atheroscler Thromb in press Pubmed
5. Shimabukuro M. MAFLD and small dense LDL cholesterol: a mechanistic link. J Atheroscler Thromb in press Pubmed
2. Shimabukuro M. L-arginine, nitric oxide, and endothelial dysfunction underlying atherosclerotic cardiovascular disease (ASCVD). J Atheroscler Thromb in press Pubmed
3. Shimabukuro M. Nonsteroidal mineralocorticoid receptor antagonists and protection against cardiovascular disease in patients with diabetes mellitus. J Atheroscler Thromb in press Pubmed
4. Shimabukuro M. MAFLD and ASCVD: plasma heparin cofactor II activity as an anti-liver fibrosis biomarker. J Atheroscler Thromb in press Pubmed
5. Shimabukuro M. MAFLD and small dense LDL cholesterol: a mechanistic link. J Atheroscler Thromb in press Pubmed
英文症例
和文著書
・島袋充生 日本糖尿病学会専門医取得のための研修必携ガイド 改訂第9版 日本糖尿病学会 印刷中・益崎裕章ほか 玄米機能成分をめぐる脳科学と分子栄養学 健康と疾患を制御する精密栄養学「何を、いつ、どう食べるか?」に、食品機能の解析と個人差を生む分子メカニズムの解明から迫る 國澤 純/編 実験医学増刊 2023年 Vol.41 No.10
